Below is a collection of Journal Articles, Reports and other peer reviewed materials. This list is far from comprehensive and will be added to over time.
"As a scientist by training and libertarian at heart, I want the everyone to be able to access the facts as they are, not as others want them to be."
Michael Choularton, Managing Director, Cannacare.
The Comprehensive Report on the Cannabis Movement and the Use of Cannabis Extract to Treat Diseases.
(http://www.slideshare.net/TheHempSolution/comprehensive-report-on-the-cannabis-extract-movement) J. Kander, 2013.
A comprehensive review of evidence that cannabis extracts can eliminate cancers and other diseases. Features information from patients, caregivers, researchers, doctors, dispensaries, and corporations.
The Cannabinoid System and Immune Modulation.
(http://www.jleukbio.org/content/74/4/486.full.pdf+html) T. W. Klein, C. Newton, K. Larsen, L. Lu, I. Perkins, L. Nong and H Friedman, Journal of Leukocyte Biology, Vol. 74, No. 4, Pages 486-496.
A Report on the Endocannabinoid system and its role in the immune system.
Low Dose Oral Cannabinoid Therapy Reduces Progression of Atherosclerosis in Mice.
(http://www.nature.com/nature/journal/v434/n7034/pdf/nature03389.pdf) S. Steffens, N. R. Veillard, C. Arnaud, G. Pelli, F. Burger, C. Staub, A. Zimmer, J. Frossard and F. Mach, 2005, Nature, Vol 434, Pages 782 - 786
Report on the treatment of Atheroscierosis in mice with THC.
Inhibition of Skin Tumor Growth and Angiogenesis In Vivo by Activation of Cannabinoid Receptors.
(http://www.jci.org/articles/view/16116/pdf) M. L. Casanova, C. Blázquez, J. Martínez-Palacio, C. Villanueva, M. J. Fernández-Aceñero, J. W. Huffman, J. L. Jorcano, and M. Guzmán, 2003, The Journal of Clinical Investigation, Vol 111, Issue 1
Report regarding the treatment of non-melanoma skin cancer by activation of Cannabinoid receptors.
Inhibition of Tumor Angiogenesis by Cannabinoids.
(http://www.fasebj.org/content/17/3/529.full.pdf+html) C. Blazquez, M. L. Casanova, A. Planas, T. G. Del Pulgar, C. Villanueva, M. J. Fernandez-Acenero, J. Aragone, J. W. Huffman, J. L. Jorcano and M. Guzman, The Journal of the Federation of Amarican Societies for Experimental Biology, Vol. 17, No. 3, Pages 529-531
Report on the results of exposure to Cannabinoids on tumor growth in animals.
Appetite Suppression and Weight Loss After the Cannabinoid Antagonist SR 141716.
(http://www.sciencedirect.com/science/article/pii/S0024320598003221) G. Colombo, R. Agabio, G. Diaz, C. Lobina, Ro. Reali, Gian L. Gessa, 1998 , Life Sciences Vol 63, Issue 8, Pages 113-117.
An article reporting a possible link between the Endo-cannabinoid system and appetite regulation. (Sorry No Free Access, SNFA)
Cannabinoid-based Drugs as Anti-inflammatory Therapeutics.
(http://www.nature.com/nri/journal/v5/n5/pdf/nri1602.pdf) T. W. Klein, 2005, Nature Reviews Immunology, Vol 5, Pages 400-411.
A review of Cannabinoids in anti-inflammatory therapeutics. (SNFA)
Signaling Pathway Associated With Stimulation of CB2 Peripheral Cannabinoid Receptor, Involvement of Both Mitogen-activated Protein Kinase and Induction of Krox-24 Expression.
(http://onlinelibrary.wiley.com/doi/10.1111/j.1432-1033.1996.0704p.x/pdf) M. Bouaboula, C. Poinot-Chazel, J. Marchand, X. Canat, B. Bourrie, M. Rinaldi-Carmona, B. Calandra, G. Le Fur and P. Casellas, 1996, European Journal of Biochemistry, Vol 237, Pages 704-711.
Description of gene expression signaling pathway involving the CB2 receptor.
Cannabinoid Receptors and Immunity.
(http://proxy.baremetal.com/druglibrary.net/crl/immune/Klein_et.al_98_Receptors_-_Immunity_ImmunolToday.pdf) T. W. Klein, C. Newton and H. Friedman, Immunology Today, Vol 797, Pages 225-233.
Review of the role of cannabinoids inthe regulation and modulation of the immune system and possible integral molecular mechanisms.
The Endogenous Cannabinoid System Regulates Seizure Frequency and Duration in a Model of Temporal Lobe Epilepsy.
(http://jpet.aspetjournals.org/content/307/1/129.full.pdf+html) M. J. Wallace, R. E. Blair, K. W. Falenski, B. R. Martin and R. J. Delorenzo, 2003, The Journal of Pharmacology and Experimental Therapeutics, Vol. 307, No. 1, Pages 129-137.
Report on the role of the endo-cannabinoid system in and the effects of cannabinoids on, epilepsy.
Targeting CB2 Cannabinoid Receptors as a Novel Therapy to Treat Malignant Lymphoblastic Disease.
R. J. McKallip, C. Lombard, M.Fisher, B. R. Martin, S. Ryu, S. Grant, P. S. Nagarkatti, and M. Nagarkatti, 2002, Blood, Vol 100, Pages 627-634.
A report demonstrating the treatment of Immuno-related tumors with cannabinoids.
A website comprised of patient experiences with Cannabis treatments as well as articles and reports by;
Lester Grinspoon, M.D., Associate Professor of Psychiatry (Emeritus) at Harvard Medical School.
James Bakalar, J.D., Lecturer in Law in the Department of Psychiatry at Harvard Medical School.